GSK Sent Avandia meta analysis before publication
GlaxoSmithKline’s Avandia is once again making the headlines after it was revealed that the peer reviewer looking at the now-notorious meta-analysis on the diabetes drug’s safety profile leaked a confidential copy of the article to the firm before it was published in the New England Journal of Medicine
![[ Beasley Allen Law Firm Logo ]](http://www.avandia-legal.com/wp-content/themes/system-unity/images/logo.png)